Enlivex Therapeutics Ltd (ENLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENLV | DERM | GALT | ||
| Company | Enlivex Therapeutics Ltd | Journey Medical Corp | Galectin Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.9700 | 8.31 | 3.08 | ||
| High | 0.9863 | 8.33 | 3.14 | ||
| Low | 0.9326 | 7.97 | 2.96 | ||
| Latest | 0.9400 | 8.01 | 3.04 | ||
| Change | +0.0062 | -0.35 | -0.11 | ||
| % Change | +0.66% | -4.19% | -3.49% | ||
| Volume | 383,800 | 99,600 | 514,900 | ||
| 20-Day Average Volume | 469,795 | 130,215 | 701,910 | ||
| Previous Close | 0.9338 | 8.36 | 3.15 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.8277 | 7.73 | 3.78 | ||
| 20-Day Raw Stochastic | 75.68% | 72.73% | 3.46% | ||
| 20-Day Relative Strength | 52.88 | 52.87 | 33.23 | ||
| Weighted Alpha | -2.10 | +89.73 | +53.60 | ||
| Today's Opinion | 64% Sell | 88% Buy | 24% Sell | ||
| Previous Opinion | 64% Sell | 88% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Sell | 64% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.25% since 01/09/26 | +10.18% since 01/09/26 | -3.49% since 01/09/26 | ||
| Low | 0.8538 on 01/13/26 | 7.15 on 01/12/26 | 2.90 on 01/14/26 | ||
| High | 1.0300 on 01/15/26 | 8.40 on 01/15/26 | 3.27 on 01/15/26 | ||
| 1-Month | |||||
| %Chg | +11.11% since 12/16/25 | +1.65% since 12/16/25 | -50.97% since 12/16/25 | ||
| Low | 0.6600 on 12/31/25 | 6.97 on 01/05/26 | 2.90 on 01/14/26 | ||
| High | 1.0300 on 01/15/26 | 8.40 on 01/15/26 | 7.13 on 12/17/25 | ||
| 3-Month | |||||
| %Chg | -14.16% since 10/16/25 | +8.24% since 10/16/25 | -39.80% since 10/16/25 | ||
| Low | 0.6600 on 12/31/25 | 6.97 on 01/05/26 | 2.90 on 01/14/26 | ||
| High | 1.8100 on 11/24/25 | 9.40 on 11/12/25 | 7.13 on 12/17/25 | ||
| 6-Month | |||||
| %Chg | -23.58% since 07/16/25 | +11.25% since 07/16/25 | +6.67% since 07/16/25 | ||
| Low | 0.6600 on 12/31/25 | 6.67 on 08/13/25 | 2.54 on 07/22/25 | ||
| High | 2.1000 on 08/15/25 | 9.40 on 11/12/25 | 7.13 on 12/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 221,667 | 226,857 | 203,090 | ||
| Shares Outstanding, K | 237,382 | 27,136 | 64,473 | ||
| Annual Sales | 0 | 56,130,000 | 0 | ||
| Annual Net Income | -15,010,000 | -14,670,000 | -47,050,000 | ||
| Last Quarter Sales | 0 | 17,630,000 | 0 | ||
| Last Quarter Net Income | -2,210,000 | -2,320,000 | -8,180,000 | ||
| 60-Month Beta | 1.52 | 0.81 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 11/14/25 | -0.09 on 11/12/25 | -0.13 on 11/14/25 | ||
| Latest Earnings Date | 03/30/26 | 03/25/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||